Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus

Published:2022 Issue: Volume: Page:
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Hara Tomoyo¹,Uemoto Ryoko²,Sekine Akiko²,Mitsui Yukari¹,Masuda Shiho¹,Yamagami Hiroki¹,Kurahashi Kiyoe¹,Yoshida Sumiko¹,Otoda Toshiki²,Yuasa Tomoyuki²,Kuroda Akio³,Ikeda Yasumasa⁴,Endo Itsuro⁵,Honda Soichi⁶,Yoshimoto Katsuhiko⁷,Kondo Akira⁸,Tamaki Toshiaki⁹,Matsumoto Toshio¹⁰,Matsuhisa Munehide³,Abe Masahiro¹,Aihara Ken-ichi²

Affiliation:

1. Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences

2. Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences

3. Diabetes Therapeutics and Research Center, Institute of Advanced Medical Sciences, Tokushima University

4. Department of Pharmacology, Tokushima University Graduate School of Biomedical Sciences

5. Department of Bioregulatory Sciences, Tokushima University Graduate School of Biomedical Sciences

6. Minami Municipal National Insurance Hospital

7. Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences

8. Kondo Naika Hospital

9. Anan Medical Center

10. Fujii Memorial Institute of Medical Sciences, Tokushima University

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_63752/_pdf

Reference38 articles.

1. 1) Fan JG and Farrell GC: Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009; 50: 204-210

2. 2) Fan JG, Li F, Cai XB, Peng YD, Ao QH and Gao Y: The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. J Gastroenterol Hepatol, 2007; 22: 663-668

3. 3) Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J and Ida K: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med, 2005; 143: 722-728

4. 4) Targher G, Day CP and Bonora E: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med, 2010; 363: 1341-1350

5. 5) Maurantonio M, Ballestri S, Odoardi MR, Lonardo A and Loria P: Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Arch Med Res, 2011; 42: 337-353

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAFLD and ASCVD: Plasma Heparin Cofactor II Activity as an Anti-liver Fibrosis Biomarker;Journal of Atherosclerosis and Thrombosis;2023-08-01